Oxyrane's Series D Round

Oxyrane raised a round of funding on November 17, 2011.

Oxyrane is a biopharmaceutical company dedicated to the development of biosuperior enzyme replacement therapies (ERT) to treat lysosomal storage diseases, a class of more than 40 rare, inherited disea…

Articles about Oxyrane's Series D Round: